바로가기메뉴

본문 바로가기 주메뉴 바로가기

Mycobacterium Kansasii Disease Presenting As a Lung Mass and Bronchial Anthracofibrosis

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2006, v.60 no.4, pp.464-468









  • Downloaded
  • Viewed

Abstract

The incidence of Mycobacterium kansasii pulmonary diseases are on the increase in Korea with the higher probability of occurrence in middle-aged and older men with underlying lung diseases Among nontuberculosus mycobacterial (NTM) infections, the clinical features of M. kansasii pulmonary infection are most similar to those of tuberculosis (TB). The chest radiographic findings of M. kansasii infection are almost indistinguishable from those of M. tuberculosis (predominance of an upper lobe infiltration and cavitary lesions), even though some suggest that cavities are more commonly thin-walled and have less surrounding infiltration than those of typical TB lesions.Although there are reports on the rare manifestations of M. kansasii infections, such as endobronchial ulcer, arthritis, empyema, cutaneous and mediastinal lymphadenitis, cellulites and osteomyelitis, the association with bronchial anthracofibrosis has not yet been reported.This report describes the first case of M. kansasii infection presenting as a lung mass in the right lower lobe with accompanying bronchial anthracofibrosis.(Tuberc Respir Dis 2006; 60: 464-468)

keywords
Mycobacterium kansasii, lung mass, anthracofibrosis, Mycobacterium kansasii, lung mass, anthracofibrosis

Reference

1.

(1997) Diagnosis and treatment of disease caused by nontuberculous mycobacteria,

2.

(2005) Mycobacterium kansasii pulmonary diseases in Korea,

3.

(2002) Management of disease due to Mycobacterium kansasii,

4.

(2003) A case report of three patients with nontuberculous mycobacterial pulmonary disease caused by Mycobacterium kansasii,

5.

(1995) National survey of mycobacterial diseases other than tuberculosis in Korea,

6.

(2005) Clinical features and follow up of 302 patients with Mycobacterium kansasii pulmonary infection:a 50 year experience,

7.

(1998) Eradication of AIDS-related disseminated Mycobacterium avium complex infection after 12 months of antimycobacterial therapy combined with highly active antiretroviral therapy,

8.

(1989) Infection with Mycobacterium avium complex in patients without predisposing conditions,

9.

(2000) A case of idiopathic CD4+ T-lymphocytopenia with disseminated Mycobacterium kansasii infection and pulmonary alvelolar proteinosis,

10.

(1998) Incidence and clinical implications of isolation of Mycobacterium kansasii: results of a 5-year, population-based study,

11.

(1999) Nontuberculous mycobacteria:defining disease in a prospective cohort of South African miners,

12.

(revinfectdis1981) Chemotherapy for pulmonary disease due to Mycobacterium kansasii efficacies of some individual drugs,

13.

(1995) Clinical manifestations and implications of coinfection with Mycobacterium kansasii and human immunodeficiency virus type 1,

14.

(2005) Mycobacterium kansasii endobronchial ulcer in a nonimmunocompromised patient,

Tuberculosis & Respiratory Diseases